Skip to main content
. Author manuscript; available in PMC: 2012 Dec 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2011 Sep 29;257(3):377–387. doi: 10.1016/j.taap.2011.09.021

Table 3.

Effects of tefluthrin and deltamethrin on the voltage dependence of activation and steady-state inactivation of sodium channels expressed in HEK-Nav1.6 cells.a

Activation Inactivationb

Condition V0.5 K n V0.5 K n
Control −29.3 ± 0.6*c 5.08 ± 0.13* 72 −64.2 ± 0.5* 6.09 ± 0.09* 66
+ Tefluthrin
    0.1 µM −35.7 ± 1.1 5.11 ± 0.21* 24 −70.3 ± 1.0 6.77 ± 0.11 22
    1 µM −39.3 ± 1.3 6.30 ± 0.34 26 −73.7 ± 1.0 6.44 ± 0.14* 20
    10 µM −44.7 ± 1.9 6.61 ± 0.32 19 −76.3 ± 1.0 6.25 ± 0.20* 16
    100 µM −48.5 ± 1.7 7.21 ± 0.34 14 −79.3 ± 1.0 6.28 ± 0.25* 13
+ Deltamethrin
    0.1 µM −31.9 ± 1.2* 5.31 ± 0.21* 17 −66.2 ± 1.3* 6.25 ± 0.24* 14
    1 µM −34.2 ± 1.0 5.25 ± 0.28* 15 −68.4 ± 1.1†§ 6.42 ± 0.26* 15
    10 µM −36.0 ± 1.2 5.88 ± 0.26* 16 −71.6 ± 1.5§ 6.32 ± 0.37* 12
a

Values calculated from fits of the data from the indicated number of individual experiments to the Boltzmann equation; V0.5, midpoint potential (mV) for voltage-dependent activation or inactivation; K, slope factor.

b

Data for prepulse potentials from −55 mV to −25 mV were omitted from fits of inactivation data to the Boltzmann equation; see text for explanation.

c

Values in each column for control and concentrations of either tefluthrin or deltamethrin that are marked with the different symbols were significantly different.